Scientists at chemical laboratory

Epidiolex for Seizures

Approval of the cannabidiol CBD oral solution Epidolex for the treatment of seizures associated with two severe and rare forms of epilepsy in children  associated with Lennox-Gastaut syndrome and Dravet syndrome.

“This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies,” said FDA Commissioner Scott Gottlieb, M.D. 

The hemp industry has anticipated this approval for a long time ile the approval provides families necessary access to CBD. It was feared that an approval by the FDA of this cannabidiol might prompt the DEA to make it harder on the non-FDA approved CBD. 

Leave a Reply

Your email address will not be published. Required fields are marked *

Translate »
Add to cart